Navigation Links
DSM Obtains Exclusive World-Wide License for Innovative Drug Delivery Technology
Date:3/11/2009

SAN DIEGO, March 11 /PRNewswire/ -- Royal DSM N.V., the global Life Sciences and Materials Sciences company headquartered in the Netherlands, today announces that DSM Biomedical obtained an exclusive world-wide license for a unique drug & biologic delivery system developed by MediVas LLC, a San Diego based biomedical company. Integrated into DSM's Trancerta(R) Drug Delivery platform, this will open up a broad range of opportunities for next generation drug delivery. DSM's activities in this field are a perfect illustration of the way DSM is leveraging its competences in Materials Sciences into Life Sciences applications.

MediVas' technology for the delivery of biologics and drugs is based on a next generation set of polymers exclusively licensed from Cornell University. Generated from research both at Cornell and at MediVas, the company has an IP portfolio containing over 60 issued or pending US patents. The polymers are biodegradable, biocompatible and bioabsorbable. Furthermore they are non-inflammatory and allow greater control over the rate and duration of release of their therapeutic payload.

The technology can be used with a diverse group of drug candidates, from proteins, peptides and nucleic acids to small molecule drugs, thus expanding the possible application areas of DSM's Trancerta(R) platform. The license DSM obtained applies for the development of drug delivery systems aimed at treating ophthalmic, (cardio)vascular, musculoskeletal diseases and at providing general pain relief. MediVas will focus its development efforts on nanoparticle based therapies in oncology, immunology and on the delivery of nucleic acids.

"Through this deal we bring in the first biodegradable polymer into DSM's Biomedical portfolio, which significantly enhances our materials competences. This will help us realize our ambition to build a portfolio of drug d
'/>"/>

SOURCE MediVas LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. STALLERGENES: Oralair(R) Grasses Obtains a Pediatric MA(1) in Germany
2. AMT Obtains License to Amgens GDNF Gene to Develop Treatment for Parkinsons Disease with AMTs Proprietary Gene Therapy Platform
3. First Molecular Tem-PCR Test to Identify Multiple Forms of Staph and MRSA Obtains CLIA Certificate
4. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
5. Kibow Biotech Obtains Australian, Chinese and Indian Patents Protecting the Composition and Basic Technology Behind Its Oral Probiotic Formulation for Chronic Kidney Failure
6. The Quigley Corporation Licenses Naturally Derived Compound For Scar Improvement; License Requires Payments Totaling $1.1 Million To The Quigley Corporation Over A Five Year Period For Exclusive Ownership
7. Transgenomic and Power3 Medical Complete Agreement for Exclusive License of Neurodegenerative Biomarker Test
8. Halozyme Therapeutics Announces Roche Begins Phase 1 Clinical Trial and Selects Fourth Exclusive Biologic Target
9. CEL-SCI Announces Expansion of Exclusive Licensing Agreement for Cancer Drug Multikine
10. Stem Cell Sciences Announces the Creation of the Worlds First Authentic Rat Embryonic Stem Cells from its Exclusively Licensed Technology
11. Orion Genomics Gains Exclusive Worldwide Rights to the IGF2 Gene for Colorectal Cancer Risk Testing Through Licensing Agreement With Johns Hopkins University
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , Sept. 19, 2014  CytRx Corporation (Nasdaq: ... company specializing in oncology, today announced that David ... at BioCentury,s 2014 NewsMakers in the Biotech Industry Conference on ... Time. The conference will take place at the Millennium ... . A live and archived webcast of ...
(Date:9/18/2014)... 18, 2014  Low T Center endorses the ... Hyattsville, Maryland earlier this ... proper patient population for testosterone therapy (TRT), as ... with TRT. Examining recent claims from studies that TRT ... epidemiological studies do not provide convincing evidence that ...
(Date:9/18/2014)... , Sept. 18, 2014   MacPractice,s MacPractice ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  MacPractice MD MU version 5.0 was ... , an Office of the National Coordinator-Authorized Certification Body ...
Breaking Medicine Technology:CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 2CytRx to Present at BioCentury's 2014 NewsMakers in the Biotech Industry Conference 3Low T Center Endorses The Joint FDA Committee Meeting on Testosterone 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 2MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 3MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 4MacPractice MD MU Achieves ONC HIT 2014 Edition Complete EHR Certification from ICSA Labs 5
... 2011 Heska Corporation (NASDAQ: ... veterinary diagnostic and other specialty veterinary products , today ... best practices research, tools and metrics for patent analysis ... Heska,s Science Strength in the top 50 of the ...
... released by SCM: (Photo:   http://photos.prnewswire.com/prnh/20111006/LA81891 ) ... of closing statements, lead trial attorney for the plaintiffs in ... asked jurors to bring a verdict of $10 million in ... for James Arnold and to consider whether the Arnolds should ...
Cached Medicine Technology:The Patent Board, IP Tracking and Analysis Firm, Ranks Heska's Science Strength in Biotechnology Industry Top 50 2Lead Trial Attorney in Clark County Hepatitis C Trial, Robert Eglet, Asks Jury to Award $10 Million Compensatory Damages for Anne Arnold, $2.5 Million for James Arnold 2
(Date:9/19/2014)... 2014 United Benefit Advisors (UBA), ... its annual Fall Meeting & Expo at the ... Illinois. With a fantastic attendance of more ... new CEO, Les McPhearson, led these thought leaders ... what is required of successful advisor firms looking ...
(Date:9/19/2014)... September 19, 2014 Script Relief, ... on all commonly prescribed high blood pressure medications. ... drug coupons and has saved its users over ... of making prescription medications more accessible and affordable, ... blood pressure medications. , High blood pressure, also ...
(Date:9/19/2014)... Indiana Fiber Network, LLC (IFN), the leading Indiana ... Fiber Transport Services, adding Point of Presence (PoP) at ... PoP at Cermak, IFN enables interconnect opportunities for Carriers, ... fiber transport service to US and Global Carriers. ... Sales and Marketing August Zehner, establishing a PoP at ...
(Date:9/19/2014)... AttorneyOne.com, a recognized authority on law, update the website ... Potassium Chloride . , The FDA announced on ... lot of Potassium Chloride Injection 10mEq per 100mL due to ... intravenously, is used to treat potassium deficiency. , The ... on the shipping cartons in a single lot where, for ...
(Date:9/19/2014)... A McLean County woman filed ... following a failed hip replacement using a DePuy XL ... Inc. and Johnson & Johnson over allegations that they ... nationally known personal injury law firm, represents defective hip ... involving defective hips. , According to the lawsuit, Owens ...
Breaking Medicine News(10 mins):Health News:United Benefit Advisors New CEO Presides Over Fall Meeting & Expo 2Health News:United Benefit Advisors New CEO Presides Over Fall Meeting & Expo 3Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 2Health News:HelpRx.info Now Providing Discounts on All Common High Blood Pressure Medications 3Health News:Indiana Fiber Network Launches Point-Of-Presence in Chicago Data Center at Cermak 2Health News:Baxter Recalls Potassium Chloride Injection: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Flood Law Group Comments on Recent Hip Replacement Lawsuit 2
... ... Fresh, Nutritious, and Creative , ... Santa Cruz, CA (Vocus) June 18, 2010 -- School’s about to start and so ... J? Switch it up with kids’ bento boxes , from Laptop Lunches. ...
... ... people of all faiths in Dallas, TX, on June 27th and 28th, 2010. Spiritual ... her love and compassion in person. , ... Dallas, TX (PRWEB) June 18, 2010 -- The ‘Hugging Saint’ Amma ( http://www.amma.org ...
... ... their new 360 Degree Guarantee and provide consumers with coverage that extends past the original ... by a standard warranty. , ... (PRWEB) June 18, 2010 -- Treadmill Doctor has announced the introduction of their ...
... ... barometer for hiring this fall, we are about to see a significant pickup in recruiting from ... (PRWEB) June 18, 2010 -- ... leading indicator for future hiring activity. “It only makes sense, says RD Whitney, CEO of Onrec ...
... ... industry lived up to its tagline - “Connecting you to good health” when it successfully ... , ... Makewell Meditour Ltd., a pioneer in India’s medical tourism industry lived up to ...
... trial of a new model for testing Alzheimer,s treatments has ... exacerbate the disease if treatment is interrupted. Scientists at ... & Co. Inc studied the effects of a class of ... these drugs might cause a build-up of proteins linked to ...
Cached Medicine News:Health News:Kids' Lunchboxes Go Bento for Easy Back to School Lunch Making, Thanks to Laptop Lunches 2Health News:The ‘Hugging Saint' Amma Visits Dallas June 27-28, 2010, Offering Spiritual Upliftment to People of All Faiths 2Health News:Treadmill Doctor 360 Degree Guarantee Extended Service Plans 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 2Health News:Onrec Predicts Significant Recruiting Activity this Fall 3Health News:Onrec Predicts Significant Recruiting Activity this Fall 4Health News:Makewell Meditour Helps Nigerian Family Find a Facility to Perform Rare Separation Surgery for Conjoined Twins 2Health News:Makewell Meditour Helps Nigerian Family Find a Facility to Perform Rare Separation Surgery for Conjoined Twins 3Health News:New model suggests feared side effect of Alzheimer's drugs is unlikely 2
Upon application to intact skin, Skin-Prep* protective wipes forms a protective film that prepares the skin for the attachment of drainage tubes, external catheters, adhesive dressings and can be...
Triad Plus Sterile Isopropyl Alcohol 70% USP Prep Pads are medium size. Each package is terminally sterilized, ensuring the safest possible product....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Sterile ... Swabsticks are primarily used ... prior to administering injections. ... to meet AAMI/ANSI/ISO 11137 ...
Medicine Products: